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PUBLIC INTEREST STATEMENT
This article provides a discussion of the ongoing research and available data on α-synuclein signalling within the scientific community. The article focuses on the neurological effects of α-synuclein signalling in health and disease, with specific contributions to Parkinson's disease pathology. We have recently published an article presenting data how α-synuclein signalling can be modulated and we are discussing these results here in the context of Parkinson's disease and neuronal/synaptic dysfunction.
neurons and the development of Lewy bodies and Lewy neurites. The main component of these inclusions is α-synuclein (Spillantini et al., 1997) which plays a crucial role in the pathogenesis of PD (Singleton et al., 2003) . However, the aetiopathology of cell death remains largely unknown, although many, varied and often interacting mechanisms have been proposed, including mitochondrial dysfunction, inflammation, oxidative stress, genetic/environmental factors and normal ageing (Chan et al., 2007; Gasser, 2010; Schapira, 2008; Sulzer, 2007) . These defects are not necessarily limited to DA neurons, but include other classes of neurons in additional brain regions, such as neurons of the locus coeruleus (Gesi et al., 2000) and the pedunculopontine nucleus (Del Tredici & Braak, 2013; Hirsch, Graybiel, Duyckaerts, & Javoy-Agid, 1987) .
So why are the dopaminergic neurons so susceptible to insults leading to synaptic loss and neuronal death in PD? The reasons are still unclear, but studies point towards the high energetic demand of these cells as a possible reason for vulnerability. For instance, unlike other neuron types, DA neurons feature a massive, and importantly unmyelinated, innervation of the forebrain (Hernandez et al., 2012 ) and an extremely high number of synapses with associated high DA release and uptake mechanisms (Andén, Fuxe, Hamberoer, & Hökfelt, 1966; Matsuda et al., 2009) . Indeed, quantitative anatomical data suggest that each DA neuron in the rat gives rise to ~100,000-250,000 synapses in the striatum (Bolam & Pissadaki, 2012) , which is ~10-1,000-fold higher than striatal spiny neurons (~300 synapses), striatal inhibitory interneurons (~5,000 synapses) (Bevan, Booth, Eaton, & Bolam, 1998; Kawaguchi, Wilson, & Emson, 1990; Kita & Kita, 1994; Tepper & Bolam, 2004) and cortical neurons (~10,000 synapses) (Lacey et al., 2005) . Dopaminergic synapses release neurotransmitters at extremely high levels (Bolam & Pissadaki, 2012) ; during each release, synaptic soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembly and disassembly generates highly reactive unfolded SNARE protein intermediates (Hernandez et al., 2012; Lang, Margittai, Holzler, & Jahn, 2002) . Thus, these terminals are potentially vulnerable to activity-dependent degeneration, with much evidence pointing to these presynaptic mechanisms as an initiation site for neurodegeneration (Gray et al., 2009 ). α-synuclein binds directly to SNARE protein synaptobrevin-2/vesicle-associated membrane protein 2 (VAMP2), acting as a chaperone for SNARE complexes (Chandra, Gallardo, Fernández-Chacón, Schlüter, & Südhof, 2005) , thereby promoting SNARE-complex assembly (Burre et al., 2010) . Interestingly, Rab GTPases can interact with components of the SNARE complex (e.g. syntaxin 4) and have been implicated in regulating vesicle trafficking from the Golgi apparatus and exocytic events of vesicle fusion (Band et al., 2002; Grigoriev et al., 2011; Takahashi et al., 2012) . Data also suggest that at least three Rab proteins-Rab11, 17 and 25-are involved in regulating apical targeting of transported vesicles (Prekeris, Klumperman, & Scheller, 2000) . A potential link between PD and Rab function is supported by the finding that Rab11 is involved in regulating dopamine transporter trafficking (Furman, Lo, Stokes, Esteban, & Gnegy, 2009 ). Thus, dysfunctional α-synuclein may contribute to synaptic loss in degeneration, in particular in dopaminergic neurons, which could be linked to Rab functions associated with vesicle trafficking and release mechanisms.
Neuronal activity depends on healthy synaptic function which in turn relies on a multitude of signalling pathways involved in vesicle release and recycling. A lack of α-synuclein function, as seen in PD, has been shown in DA neurons to cause an alteration of expression and subcellular distribution of synapsin III (Zaltieri et al., 2015) , a molecule involved in vesicle release. This has been further associated with a rearrangement of synaptic vesicle clusters (Zaltieri et al., 2015) , suggesting that α-synuclein is able to affect vesicle pool availabilities or function (Figure 1 ). In addition, data suggest that the absence of α-synuclein promotes the transport of vesicles from the reserve pool to the readily releasable pools within the synapse (Abeliovich et al., 2000) and that α-synuclein can possibly interfere with a late step in exocytosis (Larsen et al., 2006) . As α-synuclein affects DA release by modulating release probabilities (Senior et al., 2008) , it is conceivable that this is one route by which α-synuclein dysfunction is linked to dopaminergic neuronal failure. Thus, it appears that α-synuclein may be a negative regulator of neurotransmitter release, by modulating both the rate of transfer of vesicles to the readily releasable pool and the probability of vesicle fusion following synaptic stimulation. This specific mode of action could relate to the endogenous function of α-synuclein, as evidence implies that the physiological role of α-synuclein is to contribute to exocytosis of neurotransmitters at the synapse.
Associated with the enormous number of dopaminergic synapses, the axonal length of these neurons exceeds that of most other neuron types (Bolam & Pissadaki, 2012) . As a result, dysfunctional protein trafficking within these exceptionally long axons could pose an additional risk for DA neurons (Hunn, Cragg, Bolam, Spillantini, & Wade-Martins, 2015) . Indeed, trafficking of vesicles (e.g. synaptic neurotransmitter vesicles), mitochondria and ribosomes throughout the cell is dependent upon transport along microtubules, which when impaired could particularly compromise these neurons.
In this context, our recent publication in Human Molecular Genetics has reported that restoration of vesicular trafficking ameliorates phenotypes induced by α-synuclein overexpression (Breda et al., 2015) . Using a Drosophila model of PD, we tested whether α-synuclein expression affects larval NMJ function and adult fly phenotypes. Here, we found that Rab11, a small GTPase involved in trafficking of vesicles between the recycling endosome/plasma membrane (Hales, Vaerman, & Goldenring, 2002) and the trans-Golgi network (Stenmark, 2009; Wilcke et al., 2000) , reverses synaptic effects caused by α-synuclein, rescues degeneration of dopaminergic neurons, reduces protein aggregation and ameliorates behavioural defects.
Our work suggests that Rab signalling can modulate α-synuclein-mediated synaptic dysfunction (Breda et al., 2015) . Given the ubiquitous expression of Rab11, its localisation to synaptic boutons (Chan et al., 2011) and the interaction of α-synuclein with Rab GTPases (Gitler et al., 2008) , it is likely that Rab11 performs a general role in maintaining synaptic function, possibly via Rab-interacting molecules (RIMs), known mediators of synaptic homeostasis (Müller, Liu, Sigrist, & Davis, 2012; Müller, Pym, Tong, & Davis, 2011) . This broad action of Rab11 has also been seen in a Drosophila model of Huntington's disease (Steinert et al., 2012; Giorgini & Steinert, 2013) , further supporting the notion of essential RIM-mediated signalling in this disorder. Thus, Rab11 may be involved in rescuing α-synuclein-induced defects, and further implicates this part of synapse function and maintenance in therapeutic strategies (Agola, Jim, Ward, BasuRay, & Wandinger-Ness, 2011) . Notes: (A) At the level of synaptic vesicles, the C-terminal of α-synuclein binds to the N-terminal of VAMP, facilitating the formation of the SNARE complex. Once the vesicle binds to syntaxin and SNAP-25, the SNARE complex is assembled and the neurotransmitter is released. (B) Release of dopamine neurotransmitter is decreased when α-synuclein is overexpressed or mutated. High levels of α-synuclein reduce the availability of synaptic vesicles in the recycling pool by affecting vesicle endocytosis. Mutations in α-synuclein (E46K or A53T) reduce neurotransmitter release by impairing late stages of exocytosis. (C) By interacting with Rab11, α-synuclein perturbs vesicle trafficking and, in particular, the recycling endosomal pathway-contributing to the accumulation of misfolded and aggregated α-synuclein in neurons.
